| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NeuBase Therapeutics, Inc. | Chief Operating Officer | Common stock | 11,200 | $21,504 | $1.92 | 30 Mar 2022 | Direct |
| NeuBase Therapeutics, Inc. | Chief Operating Officer | Employee stock option (right to buy) | 60,180 | 24 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics, Inc. | 30 Mar 2022 | 1 | $11,904 | 4 | Chief Operating Officer | 01 Apr 2022, 16:16 |
| NBSE | NeuBase Therapeutics, Inc. | 24 Jan 2022 | 1 | $0 | 4 | Chief Operating Officer | 25 Jan 2022, 13:03 |
| NBSE | NeuBase Therapeutics, Inc. | 16 Aug 2021 | 1 | $0 | 4 | COO | 24 Sep 2021, 17:03 |